DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
70	広範脊柱管狭窄症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04483297 (ClinicalTrials.gov)	October 2020	14/7/2020	First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)	First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion Surgery	Degenerative Spondylolisthesis;Spinal Stenosis	Drug: AK1320 MS;Other: Control	Asahi Kasei Pharma Corporation	Emergent Clinical Consulting	Recruiting	22 Years	80 Years	All	40	Phase 1	Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04483297
(ClinicalTrials.gov)

October 2020

14/7/2020

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion Surgery

Degenerative Spondylolisthesis;Spinal Stenosis

Drug: AK1320 MS;Other: Control

Asahi Kasei Pharma Corporation

Emergent Clinical Consulting

Recruiting

22 Years

80 Years

All

Phase 1

Canada